Supriya Lifescience IPO to open in this week, check out the details

In the next week, another IPO is lined up to open for subscription in the primary market.

Supriya Lifescience:

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

The company’s products are being exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.

Mumbai based API Company has a modern manufacturing facility in Maharashtra spread across 23,806 sq. mts, having a reactor capacity of 547 KL/ day including 7 clean rooms. The company has also acquired a plot of land, admeasuring 12,551 sq. mt, near the present manufacturing facility, to expand its manufacturing infrastructure.

When:

The initial public offer of Supriya Lifescience will open for bidding on December 16, 2021, i.e. on Thursday.  The three-day initial public offering (IPO) will conclude on December 20, i.e. on Monday.

The anchor investors can subscribe to the IPO from 15^th of December only.

• Fresh Issue: ₹ 200 Cr
• Offer for sale: ₹ 500 crore.
• Price band: Rs 265-274 per equity share.
• Market value at the upper end of the price band: ₹ 700 crore
• Face value: Rs 2 apiece.
• Lot size: 54 shares and multiples
• Listing: NSE and BSE.
• Listing Date: 28^th December
• Lead managers: Axis Capital Limited and ICICI Securities Limited
• Promoters: Satish Waman Wagh is the promoter for the company.

Objectives of the IPO:

The company aims to utilize the funds for following purpose:

• Funding capital expenditure requirements of the company
• Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company
• Meet general corporate purposes.

Summary of Financial Information:

The company reported a net profit of Rs 123.38 crore in the fiscal year 2020-21, compared to a profit of Rs 73.37 crore in the previous year.

The revenue of the company jumped to Rs 396.22 crore in FY21 from Rs 327.71 crore in FY20. For the quarter that ended on September 30, 2021, the company reported a net profit of Rs 65.96 crore with a revenue of Rs 230.06 crore.